跳至主要内容
临床试验/CTRI/2017/03/008071
CTRI/2017/03/008071已完成未知

A prospective trial to evaluate the safety and efficacy of the STEAM (Scleral Translocation Elasto-Modulation) procedure for the treatment of glaucoma in Indian adults - STEAM-G

Aleyegn Technologies LLC0 个研究点目标入组 5 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male and female subjects are eligible for the study if they are 18 years old or older and have given informed consent
  • Have moderate to severe glaucoma (24 mm Hg to 45 mm Hg IOP) with or without visual field damage
  • Have primary open angle glaucoma, angle closure glaucoma, ocular hypertension, secondary glaucoma, previous intraocular surgery
  • Are able to follow up for one year
  • Able to provide written informed consent

排除标准

  • Patients younger than 18 years or older than 80 years
  • Patients not willing to participate in the study
  • Patients having Vernal Keratoconjunctivitis
  • Corneal Scar / corneal dystrophy / corneal degeneration
  • Inflammatory conditions
  • Patients with corneal hydrops
  • Patients with Diabetes, Thyroid Dysfunction, Collagen-Vascular Disorders, Auto-Immune Disorders; Hypertensives can be included provided there would be no change in the systemic treatment during the study period
  • Patients not able to come for follow up
  • Ultrasonic pachymetry <400 µm
  • Eyes with any ocular surface infection
  • Endothelial cell count <2000 cells/mm2

研究者

发起方
Aleyegn Technologies LLC

相似试验